Bone/Mineral Metabolism News

The risk for fractures among postmenopausal women may vary between ethnic origin groups, according to findings from the Women’s Health Initiative published in The Journal of Bone and Mineral Research.

A parathyroid hormone prodrug developed to treat hypoparathyroidism received FDA approval, according to an industry press release.

Worse physical function may be the factor contributing to an increased fracture risk for women aged 75 to 80 years with type 2 diabetes, according to a study published in JAMA Network Open.

A multidisciplinary care model can reduce the risk for subsequent fractures among adults hospitalized for a hip fracture, according to findings published in Journal of Bone and Mineral Research.

Women with primary hyperparathyroidism have similar pregnancy rates, maternal outcomes and neonatal outcomes as those without primary hyperparathyroidism, according to study data.

Osteoporosis treatment reduces the risk for hip fractures for older men just as well as it does for older women, according to a study published in Journal of Bone and Mineral Research.

Two fracture risk assessment tools incorporating femoral neck bone mineral density did not outperform femoral neck BMD alone for predicting hip fractures among adults aged 80 years and older, according to study data.

Published results showed exercise in combination with glucagon-like peptide-1 receptor agonist treatment may be an effective weight loss strategy that preserves clinically relevant site-specific bone mineral density.

Pregnancy and lactation-associated osteoporosis incidence was greater than previously reported, suggesting potentially overlooked patients, with vertebral fracture the most common type of premenopausal osteoporosis, researchers reported.